Chronic inflamation, closely associated with frailty and age-related diseases, is a hallmark of aging. Mayo Clinic researchers have discovered that inhibiting key enzyme pathways reduces inflammation in human cells in culture dishes and decreases inflammation and frailty in aged mice.
The results appear today in Proceedings of the National Academy of Sciences of the United States of America. While further studies are needed, researchers are hopeful that these findings will be a step toward treatments for frailty and other age-related chronic conditions.
In the study, researchers found that Janus kinase (JAK) inhibitors, drugs that work to block activity of JAK enzymes, decreased the factors released by human senescent cells in culture dishes. Senescent cells are cells that contribute to frailty and diseases associated with aging. Also, these same JAK inhibitors reduced inflammatory mediators in mice. Researchers examined aged mice, equivalent to 90-year-old people, before and after JAK inhibitors. Over the course of two months, the researchers found substantial improvement in the physical function of the aged mice, including grip strength, endurance and physical activity.
The Latest on: Chronic inflammation
via Google News
The Latest on: Chronic inflammation
- Inflammatory Bowel Disease Tied to a Doubling of Dementia Riskon June 26, 2020 at 11:28 am
Increased dementia risk and earlier onset of dementia in patients with IBD support a role for the gut–brain axis and chronic inflammation in progressive neurocognitive decline.
- Presence of serum amyloid A3 in mouse plasma is dependent on the nature and extent of the inflammatory stimuluson June 25, 2020 at 2:07 am
Serum amyloid A3 (Saa3) derives mainly from extrahepatic tissue and is not detected in plasma from moderately inflamed obese mice. In contrast, it is present in plasma from mice acutely inflamed by ...
- Inflammatory bowel disease linked to doubling in dementia riskon June 24, 2020 at 7:09 pm
Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, is linked to a more than doubling in the risk of developing dementia, finds new research.
- Insmed reports final results from mid-stage study of brensocatib in chronic respiratory disorderon June 24, 2020 at 6:46 pm
Following up on its first announcement in February, Insmed (NASDAQ:INSM) announces final results from a Phase 2 clinical trial, WILLOW, evaluating brensocatib (INS1007) in patients with non-cystic fib ...
- Dementia May Develop 7 Years Earlier for Adults with Inflammatory Bowel Diseaseon June 24, 2020 at 5:00 pm
Older adults with chronic inflammation of the gastrointestinal tract may develop dementia more than seven years earlier than those without the condition.
- Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5pon June 24, 2020 at 2:38 am
Li et al. investigate the mechanism behind vascular inflammation and calcification in chronic kidney disease (CKD) and show that inflammation is due to activation of the confirmed TGFBR1/TAK1 pathway, ...
- Scientists link bowel inflammation to higher risk of dementiaon June 23, 2020 at 3:56 pm
While the study does not prove IBD causes dementia, Zhang and his colleagues outlined a number of ways the two may be linked, noting chronic inflammation has been suggested to trigger processes ...
- Dementia risk doubled in adults with inflammatory bowel disease, study findson June 23, 2020 at 3:34 pm
Adults with inflammatory bowel disease are more than twice as likely to develop dementia than those without IBD, a study published Tuesday in the journal Gut found.
- People with inflammatory bowel disease might be at higher risk for dementia, study findson June 23, 2020 at 3:33 pm
If you have inflammatory bowel disease, you might be at greater risk for developing dementia, a new study found. An anti-inflammatory diet could help.
- Global Chronic Inflammatory Demyelinating Polyneuropathy Market to 2030 - Insights, Epidemiology and Forecast - ResearchAndMarkets.comon June 19, 2020 at 8:23 am
The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insights, Epidemiology, and Market Forecast-2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...
via Bing News